医療バイオテクノロジーのアーカイブ

出版倫理

出版に関する倫理基準は、特定の高品質の科学出版物を作成し、科学的発見に対する国民の信頼を確立し、人々が自分の研究や思想を評価されるようにするために存在します。

医療バイオテクノロジーのアーカイブは、国際医学ジャーナル編集者委員会 (ICMJE) の行動規範と出版倫理に関するジャーナル編集者のベスト プラクティス ガイドラインに従っています。

記事の評価

すべての原稿は査読の対象となり、学術的優秀性の基準を満たすことが期待されます。編集者を通じて承認された場合、投稿は査読者によって検討されますが、査読者の身元は著者には匿名のままとなります。

当社の研究公正チームは、たとえば、倫理、セキュリティ、バイオセキュリティ、または社会に重大な影響を与える投稿について、標準的な査読の範囲外でアドバイスを求めることがあります。当社は、特定の専門知識を持つ査読者の採用、追加の編集者による評価、投稿のさらなる検討の拒否などを含むがこれらに限定されない適切な措置を決定する前に、専門家や学術編集者に相談することがあります。

盗作

著者は、他者の言葉、数字、アイデアを出典を明示せずに使用する必要はありません。すべての情報源は、使用された時点で引用する必要があり、文言の再利用は抑制し、本文中で帰属または引用する必要があります。

他の著者による原稿から盗用されたと認められる原稿は、出版済みか未出版であるかにかかわらず拒否され、著者は追加の制裁を受ける可能性があります。公開された記事も修正または撤回する必要がある場合があります。

重複提出と重複出版

医療バイオテクノロジーのアーカイブでは、オリジナルのコンテンツ、つまり英語以外の言語を含む、これまでに出版されていない記事のみが考慮されます。以前にプレプリント サーバー、機関リポジトリ、または論文でのみ公開されたコンテンツに基づく記事が考慮されます。

このジャーナルに投稿された原稿は、検討中は他の場所に投稿してはならず、他の場所に投稿する前に取り下げなければなりません。論文が同時に他の場所に投稿されたことが判明した著者は、制裁を受ける可能性があります。

If authors have used their own previously published work, or work that is currently under review, as the basis for a submitted manuscript, they must cite the previous articles and indicate how their submitted manuscript differs from their previous work. Reuse of the author’s own words outside the methods should be attributed or quoted in the text. Reuse of the author’s own figures or substantial amounts of wording may require permission from the copyright holder and the authors are responsible for obtaining this.

医療バイオテクノロジーのアーカイブ will consider extended versions of articles published at conferences provided this is declared in the cover letter, the previous version is clearly cited and discussed, there is significant new content, and any necessary permission are obtained.

Redundant publication, the inappropriate division of study outcomes into more than one article, may result in rejection or a request to merge submitted manuscripts, and the correction of published articles. Duplicate publication of the same, or a very similar, article may result in the retraction of the later article and the authors may incur sanctions.

Citation manipulation

Authors whose submitted manuscripts are found to include citations whose primary purpose is to increase the number of citations to a given author’s work, or to articles published in a particular journal, may incur sanctions.

Editors and reviewers must not ask authors to include references merely to increase citations to their own or an associate’s work to the journal or to another journal they are associated with.

Fabrication and falsification

The authors of submitted manuscripts or published articles that are found to have fabricated or falsified the results, including the manipulation of images, may incur sanctions, and published articles may be retracted.

Authorship and acknowledgements

All listed authors must have made a significant scientific contribution to the research in the manuscript, approved its claims, and agreed to be an author. It is important to list everyone who made a significant scientific contribution. Submitting authors must provide an ORCID and we encourage all authors to provide one. Changes in authorship must be declared to this journal and agreed to by all authors. An author may change their name on a published article (see below).

Anyone who contributed to the research or manuscript preparation, but is not an author, should be acknowledged with their permission.

Submissions by anyone other than one of the authors will not be considered.

 

Conflicts of interest

Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

Editor will take reviewer misconduct seriously and pursue any allegation of breach of confidentiality, non-declaration of conflicts of interest (financial or non-financial), inappropriate use of confidential material, or delay of peer review for competitive advantage. Allegations of serious reviewer misconduct, such as plagiarism, will be taken to the institutional level.

Authors

Authors must declare all potential interests in a ‘Conflicts of interest’ section, which should explain why the interest may be a conflict. If there are none, the authors should state “The author declares that there are no conflicts of interest regarding the publication of this paper.” Submitting authors are responsible for co-authors declaring their interests.

Authors must declare current or recent funding (including article processing charges) and other payments, goods or services that might influence the work. All funding, whether a conflict or not, must be declared in the ‘Funding Statement’.

Declared conflicts of interest will be considered by the editor and reviewers and included in the published article.

Author(s) should state that the study they are submitting was approved by the relevant research ethics committee or institutional review board. If human participants were involved, manuscripts must be accompanied by a statement that the experiments were undertaken with the understanding and appropriate informed consent of each. If experimental animals were used, the materials and methods (experimental procedures) section must clearly indicate that appropriate measures were taken to minimize pain or discomfort, and details of animal care should be provided.

Editors and Reviewers

Editors and reviewers should decline to be involved with a submission when they

• Have a recent publication or current submission with any author
• Share or recently shared an affiliation with any author
• Collaborate or recently collaborated with any author
• Have a close personal connection to any author
• Have a financial interest in the subject of the work
• Feel unable to be objective

Reviewers must declare any remaining interests in the ‘Confidential’ section of the review form, which will be considered by the editor.

Editors and reviewers must declare if they have previously discussed the manuscript with the authors.

 

Corrections and retractions

When errors are identified in published articles, the publisher will consider what action is required and may consult the editors and the author’s institution(s).

Errors by the authors may be corrected by a corrigendum and errors by the publisher by an erratum.

Retracted papers will be retained online, and they will be prominently marked as a retraction in all online versions, including the PDF, for the benefit of future readers.

All authors will be asked to agree to the content of the notice.

出版後の著者名変更は、ジャーナルへの要請に基づき、文書の提出や訂正通知、他の著者への通知を必要とせずに、ジャーナルが発行した論文および引用論文に対して行われます。